La Jolla Pharmaceutical (LJPC) News and press releases

La Jolla Pharmaceutical (NASDAQ:LJPC) reported its Q1 earnings results on Monday, May 16, 2022 at 04:15 PM. Here's what investors need to know about the announcement.

La Jolla Pharmaceutical (NASDAQ:LJPC) reported $10.40 million in sales this quarter. This is a 69.53 percent decrease over sales of $34.14 million the same period last year.

What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

What are Value Stocks?

La Jolla Pharmaceutical (NASDAQ:LJPC) reported quarterly earnings of $0.11 per share. This is a 184.62 percent increase over losses of $(0.13) per share from the same period last year.

La Jolla Pharmaceutical Company (NASDAQ:LJPC), which is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases, today announced financial

La Jolla Pharmaceutical Company (NASDAQ:LJPC), which is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases, today announced financial